Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients.
Masana L, Cabré A, Heras M, Amigó N, Correig X, Martínez-Hervás S, Real JT, Ascaso JF, Quesada H, Julve J, Palomer X, Vázquez-Carrera M, Girona J, Plana N, Blanco-Vaca F.
Masana L, et al. Among authors: correig x.
Atherosclerosis. 2015 Feb;238(2):213-9. doi: 10.1016/j.atherosclerosis.2014.12.006. Epub 2014 Dec 9.
Atherosclerosis. 2015.
PMID: 25528430
Clinical Trial.